We are pleased that we now have the internal competence and capacity in place to be able to take over the final optimization from RISE, and that we can continue to develop novel products in this area as well.
Stefan Nilsson, CEO of Lumito who is looking forward to the product's upcoming verification and validation phase
We are very pleased to have Tim Nilsson on board. He has a highly relevant background; he holds a Master of Science in chemistry and is very socially competent as well as well experienced within marketing and sales. This makes him the perfect fit for the role as product specialist.
Stefan Nilsson, CEO of Lumito
RISE's statement entails that our product (instrument + staining reagent) for the reference clinics is now estimated to be ready during the second quarter, not the first as previously disclosed. The notice from RISE is regrettable, but it is of the utmost importance that we maintain a high quality when we supply the reference clinics with our product.
Stefan Nilsson, CEO Lumito
We are delighted that Andreas is joining us and that Lumito will be benefiting from his solid software development experience, which he gained with product development companies. His skills are an excellent fit with our continued development strategy, especially now that Anders Sjögren is transitioning to an advisory role for the company.
Stefan Nilsson, CEO Lumito
We are grateful for the great trust that our shareholders are placing in us; the capital we are raising now will bring stability to our forthcoming effort to launch our first product.
Stefan Nilsson, CEO of Lumito
Staining kit and a novel device developed by Lumito give hope for more accurate diagnosis by keeping the advantage of H&E staining and combining it, in one image, with luminescent data, ideal for generating ground truth for machine learning algorithms.
Krzysztof Krawczyk, R&D Manager at Lumito
When you examine the Her2 imaging based on Lumito's technology, you can readily understand the opportunities it opens for pathologists when they are able to see only the tissue they are interested in. The technology further opens the door for image processing, which may help facilitate automated diagnostics in the future.
Stefan Nilsson, CEO Lumito
It is an important step that we are now able work with the prototype on site to provide input for the further development of the beta prototype, and that we will now be able to demonstrate the functionality here in Lund to prospective customers and partners.
Stefan Nilsson, CEO Lumito
Pick a time period -
There are no items matching the current filter
There are no more items matching the current filter
Back to top